TY - JOUR
T1 - Image guidance in radiation therapy for better cure of cancer
AU - Grégoire, Vincent
AU - Guckenberger, Matthias
AU - Haustermans, Karin
AU - Lagendijk, Jan J.W.
AU - Ménard, Cynthia
AU - Pötter, Richard
AU - Slotman, Ben J.
AU - Tanderup, Kari
AU - Thorwarth, Daniela
AU - van Herk, Marcel
AU - Zips, Daniel
N1 - Funding Information:
DZ and DT receive financial and technical support from Elekta AB (Stockholm, Sweden) under a research agreement. For the MRgRT program in Tübingen, DZ and DT receive funding by the German Research Council (PAK 997/1, ZI 736/2‐1), University Hospital Tübingen, and Medical Faculty Tübingen. DZ and DT receive sponsoring for travels and scientific symposia from Elekta, Siemens, Philips, and Dr. Sennewald. DZ and DT confirm that none of the above‐mentioned funding sources were involved in the study design, in the collection, analysis, and interpretation of data and in the writing of the paper. The department of Radiation Oncology at Amsterdam UMC received research support from Varian medical systems and Viewray Inc.
Publisher Copyright:
© 2020 The Authors. Published by FEBS Press and John Wiley & Sons Ltd.
PY - 2020/7/1
Y1 - 2020/7/1
N2 - The key goal and main challenge of radiation therapy is the elimination of tumors without any concurring damages of the surrounding healthy tissues and organs. Radiation doses required to achieve sufficient cancer-cell kill exceed in most clinical situations the dose that can be tolerated by the healthy tissues, especially when large parts of the affected organ are irradiated. High-precision radiation oncology aims at optimizing tumor coverage, while sparing normal tissues. Medical imaging during the preparation phase, as well as in the treatment room for localization of the tumor and directing the beam, referred to as image-guided radiotherapy (IGRT), is the cornerstone of precision radiation oncology. Sophisticated high-resolution real-time IGRT using X-rays, computer tomography, magnetic resonance imaging, or ultrasound, enables delivery of high radiation doses to tumors without significant damage of healthy organs. IGRT is the most convincing success story of radiation oncology over the last decades, and it remains a major driving force of innovation, contributing to the development of personalized oncology, for example, through the use of real-time imaging biomarkers for individualized dose delivery.
AB - The key goal and main challenge of radiation therapy is the elimination of tumors without any concurring damages of the surrounding healthy tissues and organs. Radiation doses required to achieve sufficient cancer-cell kill exceed in most clinical situations the dose that can be tolerated by the healthy tissues, especially when large parts of the affected organ are irradiated. High-precision radiation oncology aims at optimizing tumor coverage, while sparing normal tissues. Medical imaging during the preparation phase, as well as in the treatment room for localization of the tumor and directing the beam, referred to as image-guided radiotherapy (IGRT), is the cornerstone of precision radiation oncology. Sophisticated high-resolution real-time IGRT using X-rays, computer tomography, magnetic resonance imaging, or ultrasound, enables delivery of high radiation doses to tumors without significant damage of healthy organs. IGRT is the most convincing success story of radiation oncology over the last decades, and it remains a major driving force of innovation, contributing to the development of personalized oncology, for example, through the use of real-time imaging biomarkers for individualized dose delivery.
KW - adaptive radiotherapy
KW - brachytherapy
KW - cone-beam CT
KW - image guidance
KW - molecular imaging
KW - MR-linac
KW - radiation
KW - stereotactic radiotherapy
UR - http://www.scopus.com/inward/record.url?scp=85087282649&partnerID=8YFLogxK
U2 - 10.1002/1878-0261.12751
DO - 10.1002/1878-0261.12751
M3 - Review article
C2 - 32536001
AN - SCOPUS:85087282649
SN - 1574-7891
VL - 14
SP - 1470
EP - 1491
JO - Molecular Oncology
JF - Molecular Oncology
IS - 7
ER -